CLINICAL ROLE -
Statins Linked to Lower Breast Cancer Rates, Mortality
Women with high cholesterol who take statins were 45% less likely to develop breast cancer.
Read More
Compound in Chocolate May Prevent, Treat Diabetes
A cocoa-derived compound improved the function of beta cells in diabetes patients.
Ibuprofen May Increase Blood Pressure Among Arthritis Patients
Ibuprofen use may result in hypertension for patients with arthritis and cardiovascular risks.
Small Tumors in Early Stage Breast Cancer Can Match Aggression in Larger Counterparts
Small node negative tumors can be aggressive, even if classified as clinical low risk.
Employing Zika Virus to Treat Advanced Brain Cancer
Mosquito-borne disease attacks and kills glioblastoma stem cells.
How Does Obesity Increase Cancer Risk?
Researchers zero in on the cancer-causing properties of excess abdominal fat.
Children Exposed to Debris from 9/11 Attacks Show Early Risk of Heart Disease
The terrorist attacks from September 11, 2001 on the World Trade Center continue to have widespread health effects on those exposed to the debris.
Trending News Today: Tick Salvia May Reduce Heart Disease in HIV-positive Patients
Top news of the day from across the health care landscape.
Trending News Today: GOP, Democrats Must Compromise to Ensure Healthcare Reform Success
Top news of the day from across the healthcare landscape.
Interventions that Target Asthma Symptoms Show Promise
Interventions to address asthma symptoms include allergen sensitivity testing and exposure remediation.
5 Things You Should Know About the Upcoming Flu Season
Flu season is approaching soon, and it is a great time for pharmacists to educate patients on the importance of the annual influenza vaccine.
A Look at TCA Toxicity Presentation and Treatment
In 2015, American poison centers responded to more than 10,000 tricyclic antidepressant exposures. With this level of prevalence, pharmacists should be prepared to respond to questions regarding TCA toxicity.
How Can Pharmacists Help Patients Lower Medication Costs?
There are numerous methods by which to obtain medications at a reduced cost, and pharmacists are perfectly positioned to help navigate this process
FDA Concerns Over Multiple Myeloma Immunotherapy Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
Liver Fibrosis Accelerated in Menopausal Women with HIV, HCV Co-Infection
After adjusting for chronological age, the findings showed liver fibrosis was accelerated during peri-menopause compared with pre-menopause.
Upadacitinib Achieves Top-line Results in Phase 2b Atopic Dermatitis Study
All doses of atopic dermatitis drug achieved significant improvements in skin and itch conditions.
How Pharmacists Can Help Patients Plan for Natural Disasters
Hurricane Harvey left widespread destruction in Houston, TX, and Hurricane Irma poses the same threats.
Top 10 Dirtiest Places in Pharmacy Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
Excess HDL Cholesterol May Increase Mortality Risk
Findings may change the understanding of “good” cholesterol.
Long-term Data Demonstrates Value of Enbrel Biosimilar in Rheumatoid Arthritis Patients
Switching from etanercept to biosimilar was not associated with treatment-emergent adverse events in rheumatoid arthritis.
Dual Role of Protein a Potential New Mechanism of Cancer Growth
Manipulating a specific protein could potentially drive tumor cells to self-destruct.
Newer Diabetes Drugs May Reduce Brain Pressure, Vision Loss
Benefits of GLP-1 agonists may exceed diabetes and obesity treatment.
Repurposed Cancer Drug Shows Potential in Kidney Disease
Drug found to slow cyst growth in patients with autosomal dominant polycystic kidney disease.
CMS Waives Certain Medicare Screening Requirements for Hurricane Harvey Relief
Medicare reimbursement expanded to healthcare providers caring for patients affected by Hurricane Harvey.
Trending News Today: Drug Marketing May Exaggerate Risks of Certain Conditions
Trending News Today: Eli Lilly to Cut Thousands of Positions
New Treatment Options Emerge for Tardive Dyskinesia
New FDA-approved drugs are members of a new class of vesicular monoamine transporter-2 inhibitors developed to address movement disorders.
Week in Review: September 9, 2017
A look at the top stories in pharmacy last week.
Watch
Gender Influences Hepatitis C Progression
Determining how hepatitis C progresses is important when considering therapies and the associated costs for different patient groups.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.
